David H. Randle, Ph.D. - Publications
Affiliations: | 2002 | University of Tennessee Health Science Center, Memphis, TN, United States |
Area:
Molecular Biology, Cell Biology, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2001 | Inoue K, Zindy F, Randle DH, Rehg JE, Sherr CJ. Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas. Genes & Development. 15: 2934-9. PMID 11711428 DOI: 10.1101/Gad.929901 | 0.565 | |||
2001 | Randle DH, Zindy F, Sherr CJ, Roussel MF. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages. Proceedings of the National Academy of Sciences of the United States of America. 98: 9654-9. PMID 11481442 DOI: 10.1073/Pnas.171217498 | 0.565 | |||
2000 | Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, Sherr CJ, Zambetti GP. p53-independent functions of the p19(ARF) tumor suppressor. Genes & Development. 14: 2358-65. PMID 10995391 DOI: 10.1101/Gad.827300 | 0.554 | |||
1998 | Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes & Development. 12: 2424-33. PMID 9694806 DOI: 10.1101/Gad.12.15.2424 | 0.558 | |||
Show low-probability matches. |